APA

Hubert M., Gobbini E., Couillault C., Manh T. V., Doffin A., Berthet J., Rodriguez C., Ollion V., Kielbassa J., Sajous C., Treilleux I., Tredan O., Dubois B., Dalod M., Bendriss-Vermare N., Caux C. & Valladeau-Guilemond J. (20201231). IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer. : Science immunology.

Chicago

Hubert Margaux, Gobbini Elisa, Couillault Coline, Manh Thien-Phong Vu, Doffin Anne-Claire, Berthet Justine, Rodriguez Céline, Ollion Vincent, Kielbassa Janice, Sajous Christophe, Treilleux Isabelle, Tredan Olivier, Dubois Bertrand, Dalod Marc, Bendriss-Vermare Nathalie, Caux Christophe and Valladeau-Guilemond Jenny. 20201231. IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer. : Science immunology.

Harvard

Hubert M., Gobbini E., Couillault C., Manh T. V., Doffin A., Berthet J., Rodriguez C., Ollion V., Kielbassa J., Sajous C., Treilleux I., Tredan O., Dubois B., Dalod M., Bendriss-Vermare N., Caux C. and Valladeau-Guilemond J. (20201231). IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer. : Science immunology.

MLA

Hubert Margaux, Gobbini Elisa, Couillault Coline, Manh Thien-Phong Vu, Doffin Anne-Claire, Berthet Justine, Rodriguez Céline, Ollion Vincent, Kielbassa Janice, Sajous Christophe, Treilleux Isabelle, Tredan Olivier, Dubois Bertrand, Dalod Marc, Bendriss-Vermare Nathalie, Caux Christophe and Valladeau-Guilemond Jenny. IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer. : Science immunology. 20201231.